https://bioinformatics.umg.eu/onkopus/drugon#antirheumaticagentdiseasemodifyingantirheumaticdrugdmard

Properties

label
[] antirheumatic agent--disease modifying anti-rheumatic drug (dmard)

Parents

Children

Relations

is_kegg_class
ozoralizumab
is_kegg_class
denosumab
is_kegg_class
certolizumabpegol
is_kegg_class
abrocitinib
is_kegg_class
abatacept
is_kegg_class
azathioprinesodium
is_kegg_class
ruxolitinibphosphate
is_kegg_class
sulfasalazine
is_kegg_class
azathioprine
is_kegg_class
methotrexate
is_kegg_class
methotrexatesodium
is_kegg_class
bucillamine
is_kegg_class
upadacitinib
is_kegg_class
filgotinibmaleate
is_kegg_class
baricitinib
is_kegg_class
tofacitinibcitrate
is_kegg_class
actarit
is_kegg_class
delgocitinib
is_kegg_class
adalimumab
is_kegg_class
upadacitinibhydrate
is_kegg_class
lenalidomide
is_kegg_class
auranofin
is_kegg_class
golimumab
is_kegg_class
etanercept
is_kegg_class
fedratinibhydrochloride
is_kegg_class
tacrolimus
is_kegg_class
pacritinib
is_kegg_class
leflunomide
is_kegg_class
iguratimod
is_kegg_class
penicillamine
is_kegg_class
lenalidomidehydrate
is_kegg_class
sodiumaurothiomalate
is_kegg_class
sarilumab
is_kegg_class
infliximab
is_kegg_class
tocilizumab
is_kegg_class
mizoribine
is_kegg_class
peficitinibhydrobromide